SHCBP1 and neoplasm: Our data revealed that SHCBP1 silencing inhibited tumor cell proliferation and induced cell cycle arrest and apoptosis, which indicating that targeting SHCBP1 could provide a novel therapeutic avenue for advanced PTC patients.